[go: up one dir, main page]

DK1390371T3 - Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer - Google Patents

Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer

Info

Publication number
DK1390371T3
DK1390371T3 DK02740590T DK02740590T DK1390371T3 DK 1390371 T3 DK1390371 T3 DK 1390371T3 DK 02740590 T DK02740590 T DK 02740590T DK 02740590 T DK02740590 T DK 02740590T DK 1390371 T3 DK1390371 T3 DK 1390371T3
Authority
DK
Denmark
Prior art keywords
furopyrimidines
oxazolo
well
tumor drugs
formula
Prior art date
Application number
DK02740590T
Other languages
English (en)
Inventor
Guido Bold
Andreas Martin-Kohler
Urs Sequin
Paul William Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1390371T3 publication Critical patent/DK1390371T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02740590T 2001-05-14 2002-05-13 Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer DK1390371T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8732001 2001-05-14

Publications (1)

Publication Number Publication Date
DK1390371T3 true DK1390371T3 (da) 2006-06-19

Family

ID=4544205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740590T DK1390371T3 (da) 2001-05-14 2002-05-13 Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer

Country Status (12)

Country Link
US (1) US7294633B2 (da)
EP (1) EP1390371B1 (da)
JP (1) JP4155827B2 (da)
CN (1) CN100378107C (da)
AT (1) ATE319718T1 (da)
BR (1) BR0209645A (da)
CA (1) CA2449188A1 (da)
DE (1) DE60209721T2 (da)
DK (1) DK1390371T3 (da)
ES (1) ES2259707T3 (da)
PT (1) PT1390371E (da)
WO (1) WO2002092603A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689753A4 (en) * 2003-12-04 2010-07-07 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제
EP1731523A4 (en) * 2004-04-01 2009-08-12 Takeda Pharmaceutical THIAZOLOPYRIMIDINDERIVAT
CA2605738C (en) 2005-04-25 2013-10-01 Merck Patent Gesellschaft Mit Beschraenkter Haftung Novel azaheterocyclic compounds as kinase inhibitors
DE102005061171A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
DE102005061170A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
KR20140043141A (ko) * 2006-06-22 2014-04-08 닛뽕 케미파 가부시키가이샤 항암제 내성 극복제
DE102007019691A1 (de) 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007019690A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
RU2345996C1 (ru) * 2007-07-17 2009-02-10 Андрей Александрович Иващенко Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
US8735387B2 (en) * 2008-07-15 2014-05-27 Sanofi Oxazolopyrimidines as Edg-1 receptor agonists
UY32240A (es) 2008-11-14 2010-06-30 Boeringer Ingelheim Kg Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
CN101899057A (zh) * 2010-07-21 2010-12-01 中国药科大学 嘧啶并噁唑衍生物的一种制备方法及其在医学上的用途
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
CN103087077B (zh) * 2011-11-03 2016-05-18 上海希迈医药科技有限公司 噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
CN103360407B (zh) * 2012-04-10 2016-06-22 上海希迈医药科技有限公司 一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
WO2015162518A1 (en) 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
CN104650111A (zh) * 2015-01-14 2015-05-27 中国药科大学 芳基脲及芳基酰胺取代的噁唑并嘧啶类化合物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137879A (en) 1990-03-30 1992-08-11 Dowelanco Furopyrimidin-4-imine derivatives
US5227387A (en) * 1991-09-03 1993-07-13 Dowelanco Quinoline nematicidal method
DK0682027T3 (da) * 1994-05-03 1998-05-04 Ciba Geigy Ag Pyrrolopyrimidinderivater med antiproliferativ virkning
JPH1184248A (ja) * 1997-09-12 1999-03-26 Nikon Corp 反射屈折縮小光学系
WO2002032872A1 (fr) * 2000-10-20 2002-04-25 Eisai Co., Ltd. Composes a noyau aromatique azote

Also Published As

Publication number Publication date
PT1390371E (pt) 2006-07-31
EP1390371B1 (en) 2006-03-08
BR0209645A (pt) 2004-07-06
DE60209721D1 (de) 2006-05-04
CN100378107C (zh) 2008-04-02
EP1390371A1 (en) 2004-02-25
ES2259707T3 (es) 2006-10-16
CA2449188A1 (en) 2002-11-21
US7294633B2 (en) 2007-11-13
ATE319718T1 (de) 2006-03-15
US20040152892A1 (en) 2004-08-05
JP4155827B2 (ja) 2008-09-24
CN1509291A (zh) 2004-06-30
JP2005508855A (ja) 2005-04-07
WO2002092603A1 (en) 2002-11-21
DE60209721T2 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
DK1390371T3 (da) Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
DE50310516D1 (de) Fredericamycin-derivate
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
CY1108129T1 (el) Παραγωγα 4-αμινο-6-φαινυλ-πυρρολο[2,3-δ]πυριμιδινης
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
CY1110247T1 (el) Παραγωγα βενζοκιναζολινης και η χρηση τους στην θεραπεια των διαταραχων των οστων
DE602004024375D1 (de) Carboxamidderivate
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
SE0401342D0 (sv) Therapeutic compounds
EP1643984A4 (en) USE OF PARTHENOLID DERIVATIVES AS ANTILEUKEMIC AND CYTOTOXIC AGENTS
MXPA05012953A (es) Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
ECSP055844A (es) Nuevos compuestos triciclicos
DK1558620T3 (da) Rutheniumkomplekser med anticancervirkning
NO20013414D0 (no) Ny anvendelse av melagatran
TW200504051A (en) Novel acridine derivatives and their use as medicaments